Trial Profile
Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 01 Jul 2020 Status changed from recruiting to completed.
- 20 Jun 2018 Status changed from planning to recruiting, according to a Luye Pharma Group media release.
- 06 Jun 2018 According to a Luye Pharma media release, the company expects to begin the trial this year.